S4-17.3 – Surfing NASH 3rd Anniversary Special: Interview with Frédéric Cren of Inventiva Pharma

S4-17.3 - Surfing NASH 3rd Anniversary Special: Interview with Frédéric Cren of Inventiva Pharma
As part of a Surfing NASH 3rd Anniversary Special, Louise Campbell and Roger Green interview CEO and Co-Founder of Inventiva Pharma, Frédéric Cren, to explore the trajectory of NASH therapeutics and Inventiva’s lead product candidate, lanifibranor.

This week, Surfing the NASH Tsunami celebrates its 3rd anniversary since the debut episode posted on April 15, 2020. We are offering a jam-packed special featuring individual interviews with guests Amy Articolo of Novo Nordisk, Donna Cryer of the Global Liver Institute, and Frédéric Cren of Inventiva Pharma.

In this final interview, Frédéric, Louise Campbell and Roger Green exchange ideas around, among other topics, the history and development of Inventiva’s lead product candidate, PPAR agonist lanifibranor.

If you enjoy the special, have questions or interest around Fatty Liver disease, please let us know your ideas by writing to questions@SurfingNASH.com and leaving a review wherever you download the discourse.

Stay Safe and Surf On!

Sponsoring partnerships with SurfingMASH present a multifaceted avenue for companies seeking to amplify their brand presence and engage with targeted audiences.

Sponsoring Partnerships!

Sponsoring partnerships with SurfingMASH present a multifaceted avenue for companies seeking to amplify their brand presence and engage with targeted audiences.